Tharimmune, Inc. has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 15, 2024. The company seeks to have the registration statement become effective at 4:00 p.m. EDT on July 19, 2024. This request was made under Rule 461 of the Securities Act of 1933. Tharimmune's CEO, Randy Milby, has acknowledged the company's responsibilities under the Act in the acceleration request. The company's legal counsel, Jeffrey Fessler of Sheppard Mullin Richter & Hampton LLP, has been designated to be notified once the registration statement is declared effective by the SEC.

Tharimmune, Inc. has officially requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, initially filed on July 15, 2024. The company seeks to have the registration statement become effective at 4:00 p.m. EDT on July 19, 2024. This request was made under Rule 461 of the Securities Act of 1933. Tharimmune's CEO, Randy Milby, has acknowledged the company's responsibilities under the Act in the acceleration request. The company's legal counsel, Jeffrey Fessler of Sheppard Mullin Richter & Hampton LLP, has been designated to be notified once the registration statement is declared effective by the SEC.